Skip to main content
Premium Trial:

Request an Annual Quote

Zymo Research Gets CE-IVD Mark for SARS-CoV-2 Multiplex Kit

NEW YORK — Zymo Research said on Tuesday that it has received CE-IVD marking for its Quick SARS-CoV-2 Multiplex Kit.

The real-time reverse transcription PCR test is designed for the qualitative detection of SARS-CoV-2 nucleic acid in upper and lower respiratory specimens. According to the Irvine, California-based company, the kit has a limit of detection of 10-virus copies per reaction and up to 382 samples can be analyzed for each RT-PCR run.

In August, Zymo received CE-IVD marking for its Quick SARS-CoV-2 rRT-PCR kit, which received Emergency Use Authorization from the US Food and Drug Administration in May. 

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.